CIK 0001510964 · Non-accelerated filer<br>Smaller reporting company
CV Sciences, Inc.
Sign in to watch- Ticker
- CVSI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800944970
- Phone
- 866-290-2157
- Business address
- 9530 PADGETT STREET, SUITE 107, SAN DIEGO, CA, 92126
- Former names
- CannaVEST Corp., Foreclosure Solutions, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-07 | CHEEVER CHARLIE E III 10% owner | Purchase | +94,854 | $0.02 | $2K | 26,648,711 |
| 2026-08-04 | CHEEVER CHARLIE E III 10% owner | Purchase | +108,000 | $0.02 | $2K | 26,553,857 |
| 2026-07-31 | CHEEVER CHARLIE E III 10% owner | Purchase | +1,730,000 | $0.02 | $35K | 26,445,857 |
| 2026-07-29 | CHEEVER CHARLIE E III 10% owner | Purchase | +60,000 | $0.02 | $1K | 24,715,857 |
| 2026-07-28 | CHEEVER CHARLIE E III 10% owner | Purchase | +1,830,000 | $0.02 | $37K | 24,655,857 |
| 2026-07-24 | CHEEVER CHARLIE E III 10% owner | Purchase | +470,075 | $0.02 | $9K | 22,825,857 |
| 2026-07-22 | CHEEVER CHARLIE E III 10% owner | Purchase | +272,500 | $0.02 | $5K | 22,355,782 |
| 2026-07-21 | CHEEVER CHARLIE E III 10% owner | Purchase | +335,000 | $0.02 | $7K | 22,083,282 |
| 2026-07-17 | CHEEVER CHARLIE E III 10% owner | Purchase | +749,000 | $0.02 | $15K | 21,748,282 |
| 2026-07-16 | CHEEVER CHARLIE E III 10% owner | Purchase | +91,387 | $0.02 | $2K | 20,999,282 |
| 2025-02-18 | Corroon James Michael Jr. Director | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2025-02-18 | Grasser Joerg Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +2,350,000 | 2,350,000 | ||
| 2025-02-18 | Dowling Joseph D Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +3,000,000 | 3,000,000 | ||
| 2025-02-18 | McCorkle William Director | Grant or award · Stock Optoin (right to buy) | +500,000 | 500,000 | ||
| 2024-06-20 | McCorkle William Director | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2024-06-20 | Corroon James Michael Jr. Director | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2024-06-20 | Grasser Joerg Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +2,350,000 | 2,350,000 | ||
| 2024-06-20 | Dowling Joseph D Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +3,000,000 | 3,000,000 | ||
| 2023-03-15 | Dowling Joseph D CEO | Grant or award · Employee Stock Option (right to buy) | +2,500,000 | 2,500,000 | ||
| 2023-03-15 | Grasser Joerg CFO | Grant or award · Employee Stock Option (right to buy) | +1,250,000 | 1,250,000 |
Page 1 of 9 · 163 trades